Movatterモバイル変換


[0]ホーム

URL:


CN119082008A - A method for obtaining gubernaculum testis mesenchymal stem cells from mouse gubernaculum testis - Google Patents

A method for obtaining gubernaculum testis mesenchymal stem cells from mouse gubernaculum testis
Download PDF

Info

Publication number
CN119082008A
CN119082008ACN202411273988.9ACN202411273988ACN119082008ACN 119082008 ACN119082008 ACN 119082008ACN 202411273988 ACN202411273988 ACN 202411273988ACN 119082008 ACN119082008 ACN 119082008A
Authority
CN
China
Prior art keywords
cells
mesenchymal stem
culture
gubernaculum
stem cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202411273988.9A
Other languages
Chinese (zh)
Inventor
段守兴
陈依依
蒋学武
谢瑶
庄扬沐
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Huazhong University of Science and Technology Union Shenzhen Hospital
Original Assignee
Huazhong University of Science and Technology Union Shenzhen Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Huazhong University of Science and Technology Union Shenzhen HospitalfiledCriticalHuazhong University of Science and Technology Union Shenzhen Hospital
Priority to CN202411273988.9ApriorityCriticalpatent/CN119082008A/en
Publication of CN119082008ApublicationCriticalpatent/CN119082008A/en
Pendinglegal-statusCriticalCurrent

Links

Classifications

Landscapes

Abstract

The invention discloses a method for obtaining mesenchymal stem cells by means of mouse testis induced banding culture. The method comprises the steps of drawing materials of testicle zona guiding tissues, digestion of zona guiding tissues, enrichment and purification of zona guiding cells and the like. The invention enriches the induced cells by partially digesting tissues with collagenase, effectively screens out fibroblasts by a transfer method, carries out passage purification on mesenchymal stem cells by pancreatin punctate digested cell colonies, carries out mass amplification, and finally carries out passage culture until a third generation mesenchymal stem cell bank is established. The culture method has the advantages of high speed, high yield and simple raw material sources, and the mesenchymal stem cells obtained by culture have high purity, have multidirectional differentiation potential and reproduction regulation and control functions, can express reproduction regulation and control related genes, and can be used for researching the disease mechanism and related treatment of pediatric cryptorchism.

Description

Method for obtaining testis induced mesenchymal stem cells by mouse testis induced banding culture
Technical Field
The invention belongs to the technical field of stem cell culture, and particularly relates to a method for obtaining testis induced mesenchymal stem cells from mouse testis induced banding culture.
Background
Cryptorchidism is the most common congenital abnormality in newborns, with a reported incidence of 2% -4%. Until recently, the molecular etiology of this syndrome was unknown. Cryptorchid may be part of a more extensive testicular dysplasia syndrome, a known risk factor for infertility and testicular cancer, thus requiring surgical intervention.
Development of testicular zone (gubernaculum testis, GT) plays a critical role in the process of testicular descent. The testis guiding belt is divided into a guiding belt ball and a guiding belt rope, and in the testis descending process, the guiding belt ball and the guiding belt rope sequentially undergo the processes of enlargement and extension, and the guiding belt ball is relatively close to the inner ring of the inguinal canal, so that the testis and the epididymis are pulled by the guiding belt ball to enter the inguinal canal. At the same time, the massive swelling of the stroma of the approach ball helps to enlarge the inguinal channel, a prerequisite for the subsequent passage of testes through the groin. It has been demonstrated that part of the cremaster muscle in rats is differentiated from peripheral mesenchymal cells of the testes with the balls, and that these mesenchymal cells present expression of immature myogenic proteins, which cause rhythmically contractile action to direct the testes down to the scrotum.
It is not clear what drives this morphological change in the form of germ-like development of testis induction. Studies show that the front end of the testis induction belt of a newborn rat can express a myogenic stem cell marker, which indicates that a certain cell in the testis induction belt tissue has multipotent stem and can differentiate into muscle cells. At present, no related study is performed to extract testis induction belt tissues for in vitro cell culture.
Mesenchymal stem cells (MESENCHYMAL STEM CELLS, MSCs) are a heterogeneous subpopulation of stromal stem cells that can be isolated from many adult tissues. They can differentiate into cells of the mesodermal lineage, such as adipocytes, osteocytes and chondrocytes, as well as cells of the other embryonic lineages. They are relatively easy to separate, combine their ability to self-renew and multipotency, making mesenchymal stem cells a promising therapeutic option for a variety of clinical diseases. Mesenchymal stem cells can interact with cells of the innate and adaptive immune systems to regulate several effector functions.
At present, due to tissue specificity and operation technical barriers of testis induction, a plurality of rats are used for culturing mesenchymal cells of testis induction. Compared with rats, the method has the advantages of simple and easy feeding of mice, short gestation period, stable embryo and easier extraction of testis zona induction tissues of newborn mice. In the process of screening rat testis induced cells by using an in vitro culture method, various cells are mixed and difficult to purify and expand in large quantities. The mice have small tissue volume of the induced belt, are not tightly adhered with the abdominal wall, and are easier to screen and purify. The multidirectional differentiation potential, the high proliferation capacity and the hormone regulating function of the testicle induced mesenchymal cells are never confirmed, so that a new thought is provided for researching the etiology mechanism of cryptorchidism, and a new direction is opened for the stem cell treatment of diseases and the development of related medicaments.
Disclosure of Invention
Aiming at the defects of the prior art, the project provides a method for obtaining mesenchymal stem cells by carrying out the induction culture on the testes of mice. The mesenchymal stem cells are cultured in high yield and high purity by utilizing the mouse induced tissue, and the obtained cells have MSCs phenotype and multidirectional differentiation potential and accord with the international cell therapeutic society (ISCT) standard. Compared with MSCs from umbilical cords and other sources, the genomics expresses more myogenic differentiation related genes, and is more beneficial to research on cryptorchism etiology and genomics research.
The invention aims to provide a method for obtaining testis induced mesenchymal stem cells from mouse testis induced tissue culture, which comprises the following steps:
S1, separating the zona pellucida tissue from a male mouse which is newly born for 0-3 days, and cleaning the zona pellucida tissue;
S2, adding 1mg/mL type I collagenase into the induced zone tissue for digestion and dispersion, transferring to a culture bottle, adding a culture medium for standing primary culture, and changing the culture medium after the primary culture is carried out until cells are attached;
S3, when the fusion rate of the adherent cells reaches 80%, carrying out subculture after punctiform digestion of cell colonies by trypsin, and establishing a cell bank until the 3 rd generation of subculture to obtain the testicular induced mesenchymal stem cells.
Preferably, the step S1 of cleaning the tape tissue is to clean the tape tissue 3 times with sterile PBS with 15% mass fraction, then soak the tape tissue with penicillin/streptomycin mixed solution for 3min, and then clean the tape tissue 3 times with sterile PBS with 15% mass fraction.
Preferably, in the step S2, 1mg/mL type I collagenase is added to the tape tissue for digestion and dispersion, and 3mL 1mg/mL type I collagenase is added to 10 tape tissues for digestion and dispersion.
Preferably, the digestion in the step S2 is dispersed for 2 hours at 37 ℃ and 250 r/min.
Preferably, the culture medium in the step S2 comprises 15% of fetal bovine serum, 1% of penicillin/streptomycin mixed solution and the balance of high-sugar DMEM culture medium without phenol red according to volume fraction.
Preferably, the conditions of the stationary primary culture in the step S2 are 5% CO2, 37 ℃ and saturated humidity.
Preferably, the dot-shaped digestion in the step S3 is to firstly drop 1 drop of trypsin for digestion for 3min, and then add 1mL of trypsin for complete dispersion digestion for 3min. The second purpose of the invention is to provide the testicular traction mesenchymal stem cells prepared by the method.
The third object of the invention is to provide the application of the testicular guide mesenchymal stem cells in inducing differentiation of adipocytes, bone cells and chondrocytes.
The second object of the invention is to provide the application of the testicular traction mesenchymal stem cells in preparing a product for treating cryptorchidism or hormone regulation.
Compared with the prior art, the invention has the following beneficial effects:
(1) The method has high growth rate and proliferation rate of the TG-MSCs cultured by the method relative to MSCs from umbilical cord sources. 0.2g of umbilical cord Wharton's jelly tissue is cultured and passaged under the same conditions by the same operation, and the umbilical cord needs to be cultured for 26 days and the testis introduction tissue needs to be cultured for only 20 days based on the second generation cells with the fusion rate of 80% in the culture dish with the same volume.
(2) The yield is high, the volume of the mouse testis induced band tissue is small, the weight is light, each induced band tissue is less than 1 mug, 10 induced band tissues are extracted for cell culture, the cells are passaged to the third generation for cell count, the cell quantity obtained in the third generation is 2.7 tens of millions of cells, and the cell quantity obtained in the fifth generation is 2.43 hundred million cells, which is equivalent to 24.3 hundred million cells generated per milligram of testis induced band tissue. Fifth generation mesenchymal stem cells are generally selected clinically as a treatment. Umbilical cord-derived MSCs produced only 16.45 hundred million 3 rd generation cells and 148.05 hundred million 5 th generation cells per gram of huagaong gum, and the yield of testicular-introduced mesenchymal stem cells was far higher than that of umbilical cord mesenchymal stem cells.
(3) The purity is high, the expression condition of the MSCs phenotype CD71/CD90/CD44/CD34/CD45 is detected by a flow cytometry, and the detection result proves that the GT-MSCs have the MSCs phenotype and meet the international cytotherapeutic society (ISCT) standard.
(4) The multidirectional differentiation potential is that the immunofluorescence technology is used for detecting the mesoderm marker PDGFR-alpha/NKX 2.5, and inducing osteogenesis, adipogenesis and chondrogenesis differentiation are all induced to succeed in differentiation, which proves that GT-MSCs can express the multidirectional differentiation related genes, have the multidirectional differentiation potential and accord with the international cytotherapeutic society (ISCT) standard.
The method comprises the steps of drawing materials of testicle zona guiding tissues, digestion of zona guiding tissues, enrichment and purification of zona guiding cells and the like. The invention enriches the induced cells by partially digesting tissues with collagenase, effectively screens out fibroblasts by a transfer method, performs passage to purify mesenchymal stem cells by punctiform digested cell colonies of trypsin, performs mass expansion, and finally performs passage culture to a third generation to establish a mesenchymal stem cell bank. In the early stage, the mesenchymal stem cells obtained by digestion with trypsin are not as large in number as the mesenchymal stem cells obtained by short-time digestion, and the mesenchymal stem cells obtained by passaging after complete digestion of tissue mass with trypsin are not as pure as the mesenchymal stem cells obtained by punctate digestion.
The culture method has the advantages of high speed, high yield and simple raw material sources, and the mesenchymal stem cells obtained by culture have high purity, have multidirectional differentiation potential and reproduction regulation and control functions, can express reproduction regulation and control related genes, and can be used for researching disease mechanism and related treatment of pediatric cryptorchism.
Drawings
FIG. 1 shows the morphology of the second generation GT-MSCs under a phase contrast microscope in example 1, cells were long fusions, with antennae, as adherent cells, and scale was 250. Mu.m.
FIG. 2 is a graph showing the proliferation of cells obtained by measuring the OD of GT-MSCs grown for 0-7 days using CCK-8 method in example 1.
FIG. 3 is a statistical histogram of flow cytometry unimodal plots of positive cells for the GT-MSCs marker clusters CD71, CD90 and CD44 and negative cells for CD45, CD34 according to example 1.
FIG. 4 is a flow cytometry unimodal plot of positive cells for the GT-MSCs marker clusters CD71, CD90 and CD44 and negative cells for CD45, CD34 in example 1.
FIG. 5 is an immunofluorescence staining pattern of TG-MSCs expressing mesodermal markers NKX2.5 and PDGFR-alpha.
FIG. 6 is a graph showing the results of the multi-directional induced differentiation test of GT-MSCs in example 1, wherein A is a graph showing the results of alizarin red staining after osteogenic induced differentiation, B is a graph showing the results of oil red O staining after adipogenic induced differentiation, and C is a graph showing the results of alisxin blue staining after chondrogenic induced differentiation.
FIG. 7 shows nucleic acid gel electrophoresis patterns of the G-protein coupled receptor gene RXFP2 (receptor of the primary product INSL3 of testicular interstitial cells), which is a normal control group (NC), a solvent control group (DM) and an administration experimental group (construction of a mouse cryptorch model, administration of Diethylstilbestrol (DES) treatment at concentrations of 0.1. Mu.g/kg.d, 1. Mu.g/kg.d, 10. Mu.g/kg.d, 100. Mu.g/kg.d (labeled as 0.1. Mu.g, 1. Mu.g, 10. Mu.g, 100. Mu.g, respectively), respectively, and β -actin as an internal reference gene.
Fig. 8 is a statistical plot of the relative expression levels of Nanog and Oct4 proteins in Normal Control (NC), solvent control (solvent DMSO, labeled DM on the graph), chloroquine (CQ, autophagy flow blocker) treated for 4H (labeled CQ on the graph), DES treated for 24H (labeled DES24H on the graph), des+cq treated for 24H (labeled d+c24h on the graph) GT-MSCs cells, a is a plot of Western Blot results, B is a Nanog protein level histogram, C is an Oct4 protein level histogram, and results in B and C are mean ± SD, n=3, and are shown as significant differences between the treated groups and NC at levels P <0.05, P <0.01, respectively.
FIG. 9 is a standard curve of the protein prepared in example 6.
FIG. 10 shows Western blot SDS-PAGE gel of G protein coupled receptor RXFP2, A. Test protein was taken from mouse testis-carrying tissue, NC was no treatment control, DM was solvent control (DMSO treatment), mice in the experimental group were given DES treatment (subcutaneously injecting DES into the master mice to extract testis-carrying tissue from the young mice), DES concentrations were 0.1. Mu.g/kg.d (labeled as DES 0.1 on the graph), 1. Mu.g/kg.d (labeled as DES1 on the graph), 10. Mu.g/kg.d (labeled as DES10 on the graph), 100. Mu.g/kg.d (labeled as DES100 on the graph), wherein GAPDH was an internal reference protein, B. Protein second generation GT-MSCs, NC was no treatment control, DM was solvent control, and the experimental group was given second generation GT-MSCs treatment at a concentration of 0.01. Mu.g/kg.d (labeled as DES 0.01 on the graph), 0.1. Mu.g/kg.d (labeled as DES 0.1 on the graph), 1. Mu.g/kg.d (labeled as DES10 on the graph), 100. Mu.g/kg.d (labeled as DES100 on the graph), and a relative mean value of 1. Mu.g/kg.d (labeled as DES 2 on the graph) were shown below, respectively, wherein the mean value of the protein concentration and the protein concentration between the protein concentration and the protein concentration was 10% 1% were not shown in the graph.
FIG. 11 shows protein levels of LC3 (LC 3 is an autophagy degradation substrate marker) and P62 (autophagy degradation substrate marker) in Western Blot detection GT-MSCs treated with DES12H (DES 12H), 24H (DES 24H), 48H (DES 48H) and DES+CQjointly for 12H (D+C12H), 24H (D+C24H), 48H (D+C48H), wherein GAPDH is an internal control, A is the Western Blot detection result of LC3, B and C are statistical graphs of relative expression levels of LC3 protein, D is the Western Blot detection result of P62, E and F are statistical graphs of relative expression levels of P62 protein (mean.+ -. SD, n=3, and X represent significant differences between the treatment groups and NC at levels of P <0.01 and P <0.001, respectively).
Detailed Description
The following examples are further illustrative of the invention and are not intended to be limiting thereof.
The experimental animals are Kunming mice, 8-10 weeks old, free of mouse specific pathogens, purchased and fed to Shanshi university medical school. All animals were well nourished and had normal mental and neurological status. The Shanzhi university college of medicine, the ethical committee for animal experiments approved the use of Kunming mice as subjects (No. SUMC 2018-064).
Phenol red-free high-sugar DMEM medium was purchased from the bio-tech company of the wunpro, with the product number PM150316.
Example 1
A method for obtaining mesenchymal stem cells with multidirectional differentiation potential and reproductive regulation function by carrying out induced banding culture on a mouse testis comprises the following specific steps.
(1) The male mice born for 0-3 days are killed by soaking in ethanol water solution with the volume fraction of 75% for 15min, the mice are soaked in iodophor solution for 15min, soaked and disinfected in ultra-clean bench by ethanol water solution with the volume fraction of 75% for 5min, meanwhile, the iodophor attached to the surfaces of the mice is removed, and the disinfected mice are put into physiological saline for cleaning.
(2) The mice were placed in sterile dishes with sterile gauze for dissection, the lower abdominal skin was cut transversely, then longitudinally to the anus, and the skin was spread to expose the bladder and testes on both sides of the bladder. The testis was gently lifted with micro forceps and the testis, epididymis and the tape were cut off together.
(3) The removed tissue was placed in 15% by mass sterile drops of phosphate buffered saline (PBS, available from Lonza), and the tissue fluid and blood were washed 3 times with 15% by mass sterile PBS until washed. Separating out the ribbon tissue with microscopic forceps, soaking the separated ribbon tissue in penicillin/streptomycin mixed solution (purchased from Lonza) for 3min, washing with PBS with 15% sterile mass fraction for 3 times,
(4) The prepared tape tissue was placed in a 15mL sterile centrifuge tube, about 3mLI collagenase (1 mg/mL concentration) was added (from Worthington) (10 tape tissues from 5 mice were added with 3mLI collagenase), and the tape tissue was loosened by digesting fibrin around the tape tissue with a constant temperature shaker at 37℃at 250r/min, and the interstitial cells of the tape were allowed to climb out of the tissue mass.
(5) An equal volume of phenol red-free high-sugar DMEM medium (composition by volume: 15% fetal bovine serum, 1% penicillin/streptomycin mixture, balance phenol red-free high-sugar DMEM medium) containing 15% Fetal Bovine Serum (FBS) was added to terminate the digestion of type I collagenase, 1200rmp was centrifuged for 5min, the supernatant was discarded, and 5mL of phenol red-free high-sugar DMEM medium containing 15% fetal bovine serum was added to fully resuspend the obtained mesenchymal stem cells and transferred into a sterile culture flask.
(6) Cells were placed in a 5% CO2, 37℃saturated humidity incubator for stationary culture and medium was changed after the cells had attached (about 3 days).
(7) The cell growth was observed with an inverted microscope. And (5) carrying out passage after the cell fusion rate reaches about 80%. Cell colonies were punctuated with trypsin (Gibco, life technologies) and passaged, and repeatedly subcultured to passage 3 to establish a cell bank to obtain testicular-introduced mesenchymal stem cells (GT-MSCs). The punctiform digestion method comprises adding 1 drop of pancreatin to the local part of the cells in the form of agglomerate, and then adding 1mL pancreatin to completely disperse and digest for 3min.
10 Pieces of the zona pellucida tissues are extracted to obtain one dish (25 cm2) of primary cells, and the cell quantity is 100 ten thousand. After 20 days of culture, the cell fusion rate reaches 80%, and subculture can be performed. The morphology and cell size of the second generation GT-MSCs are shown in FIG. 1. As can be seen in FIG. 1, GT-MSCs are typically fibroblast-like, in elongated, adherent, and fusiform morphology.
Example 2
This example is a study of the growth rate of the cells obtained in example 1, and the growth curve of the cells was examined by CCK-8 (Cell Counting Kit-8), and the specific procedure and results are as follows.
(1) Collecting cells (third generation) grown in 2-3 days (logarithmic growth phase), preparing single cell suspension, regulating concentration of single cell suspension after cell counting, adding 100 μl single cell suspension into 96-well plate, and regulating density of cells to be tested to 4000-5000 cells/well.
(2) The culture was performed with a cell culture medium, which was a high-sugar DMEM medium (15% fbs, 1% penicillin/streptomycin mixed solution) containing no phenol red, and the 96-well plate was placed in a 5% CO2, 37 ℃ incubator for 1-7 days. Once per day at the same time point.
(3) The cell culture medium was discarded, and the floating dead cells were removed by washing 1 time with PBS, and 100. Mu.L of fresh phenol red-free high-sugar DMEM medium and 10. Mu.L of CCK-8 solution (Abbe 50003) were added to each well.
(4) After further incubation in a cell incubator for 1 hour, the absorbance (OD value) at a wavelength of 450nm was detected by an enzyme-labeled instrument, and the detection was repeated 3 times to obtain an average value. Daily test results were recorded.
(5) The time axis is used as the horizontal axis, the absorbance (OD value) is used as the vertical axis, the proliferation curve of the cells is plotted, and the exponential growth phase of the cells can be seen from the proliferation curve of the cells.
As can be seen from FIG. 2, GT-MSCs grew to log phase for 2-4 days. 10 pieces of the tissue with the leading tape are taken and cultured according to the culture method, and after subculturing to the third generation of cells, the cell count is carried out, and the cell quantity is 2.72 multiplied by 107.
Example 3
This example demonstrates the characterization of the cell phenotype of the mesenchymal stem cells obtained in example 1 by flow cytometry and immunofluorescence, with the following procedure and results.
1. Flow cytometry
(1) Article preparation, the antibodies FITC anti-mouse CD90.2, FITC anti-mouse CD71, APC anti-mouse CD34, APC anti-mouse CD45 (Biolegend), fetal bovine serum FBS (purchased from Propoxel) were removed and placed on ice in the dark;
(2) Taking the 3 rd generation GT-MSCs cells in the logarithmic growth phase, slightly blowing the cells to avoid cell disruption before the digestion method, centrifuging the digested cells at 1500rpm for 5min, and collecting the cells;
(3) Preparing a 1.5mL EP tube, grouping according to the tested antibodies to prepare antibody marks, and leaving a blank control tube;
(4) Discarding the supernatant of the collected cells, adding 1mL of 4 ℃ precooled PBS (Biyun Tian), and re-suspending the cells into single-cell suspension;
(5) 1mL of cell suspension is sucked and added into a 1.5mL EP tube, and the cells are washed twice by precooled 1mL of PBS, and the centrifugal machine is precooled at 4 ℃ in advance, and then the cells are collected by centrifugation for 5min under the condition of 4500 rpm;
(6) Preparing a sealing liquid, namely preparing the sealing liquid according to the volume ratio of goat serum to PBS=1:9, and adding 100 mu L of sealing liquid into each tube;
(7) Discarding PBS, adding the prepared sealing solution into cells, re-suspending into cell suspension, adding 100 mu L of the sealing solution into each EP tube, and incubating for 10min;
(8) After the incubation is completed, antibody (FITC anti-mouse CD71(2.5μL/100μL)、APC anti-mouse CD34(2.5μL/100μL)、APC anti-mouse CD45(2.5μL/100μL) or FITC anti-mouse CD90.2 (4. Mu.L/100. Mu.L) is added to each tube in proportion, and the mixture is placed on ice and incubated for 15min in a dark place;
(9) Placing the incubated cells in a 4 ℃ precooling centrifuge, centrifuging for 5min at 4500rpm, and discarding the supernatant;
(10) Add 500. Mu.L PBS per tube, resuspend the cell suspension and filter with cell filtration mesh;
(11) And (5) detecting in a light-shielding machine.
As can be seen from fig. 3 and 4, the cell phenotype was established by flow cytometry using a panel of surface markers, showing positive cells for clusters CD71, CD90 and CD44 of MSCs markers and their negative cells for CD45, CD34, with CD90 and CD44 expression of up to 97.7% and 99.1%, CD 44-0.302% and CD 34-2.06%. The GT-MSCs are indeed shown to have a MSCs phenotype, which meets the International Society of Cytotherapy (ISCT) standard.
2. Immunofluorescent staining
Sterilizing the super clean bench, placing the prepared articles on the super clean bench, sterilizing by ultraviolet irradiation for 30min, taking out the reagent, and re-heating at room temperature.
(1) The preparation of the cell climbing sheet comprises the steps of taking a 24-hole culture plate, adding a small amount of high-sugar DMEM culture medium without phenol red at the bottom of the culture plate, uniformly spreading the culture plate bottom, putting the cell climbing sheet at the bottom of the 24-hole culture plate, and tightly attaching the cell climbing sheet to the plate bottom;
(2) Taking second generation (P2) cells in an exponential growth phase, and carrying out passage on a 24-pore plate according to a proper density, and growing on a climbing plate, wherein the cell density is not excessive, and preferably, the cells do not have stacking adhesion growth, so that the fluorescence of the photographed cells is clear and complete;
(3) Discarding the high-sugar DMEM culture medium without phenol red when the cell is attached to the wall and grown and fused to about 40%, if the cell needs to be added with medicine treatment, the cell density can reach 30%, and then the DES treatment is carried out for 24 hours;
(4) Discarding the culture medium, slowly blowing with precooled PBS, cleaning away suspended and detached dead cells, repeating for 3 times for 3min each time;
(5) Adding 200 mu L of paraformaldehyde with the mass fraction of 4% into each cell, and fixing the cells for 15min;
(6) Washing with PBS again for 3 times and 5min each time;
(7) 200 mu L of Triton X-100 aqueous solution with the volume fraction of 0.5% is added into each cell at room temperature to puncture the cell membrane, so that the primary antibody binding solution can easily pass through the cell membrane to enter cytoplasm;
(8) Repeating step (5);
(9) Dripping 200 mu L of goat serum with the volume fraction of 10% on each hole of cells for sealing, and standing at room temperature for incubation for 45-60 min;
(10) Preparing primary antibodies, namely diluting the primary antibodies according to the specification ratio of PDGFR-alpha (purchased from Abcam (U.S.), ab97355, dilution ratio of 1:200), NKX2.5 (purchased from CST Co (U.S.), 3868, dilution ratio of 1:200);
(11) Discarding the serum sealing liquid, not washing, adding 200 mu L of primary antibody into each hole, and placing the mixture in a refrigerator at a temperature of 4 ℃ for incubation overnight;
(12) Discarding the primary antibody, washing with PBS for 10min, and washing for 3 times;
(13) Dripping secondary antibody (Alexa Fluor 488 marked goat anti-rabbit IgG (H+L) (1:500) to incubate for 60min at room temperature, and taking care of light-shielding operation;
(14) Repeating step (5);
(15) Dripping anti-fluorescence quenching agent containing DAPI (1 mg/mL) to fully spread the climbing sheet;
(16) Lightly prying the climbing sheet by forceps, reversely buckling the climbing sheet on a glass slide, sealing the climbing sheet by transparent nail polish and fixing the climbing sheet on the glass slide to prevent the climbing sheet from moving;
(17) And placing the prepared climbing sheet under a confocal microscope, observing and shooting, and paying attention to light-shielding operation.
As can be seen from FIG. 5, TG-MSCs expressed mesodermal markers NKX2.5 and PDGFR-alpha, further demonstrating the potential of TG-MSCs for multipotent differentiation.
Example 4
This example a pluripotency study was performed on the testicular traction mesenchymal stem cells obtained in example 1 by an experiment of inducing multidirectional differentiation, with the following specific procedures and results.
1.1 Adipogenic Induction of differentiation
(1) Inoculating 40 ten thousand third-generation cells onto a six-hole plate according to a plating method to uniformly distribute the cells, discarding the high-sugar DMEM culture medium without phenol red when the fusion density reaches 80% -90% after the cells are subjected to wall-attached culture for 2 days, rinsing 3 times by PBS, discarding the PBS, and adding 2mL of fat-forming induced differentiation culture medium A (purchased OriCell, MUXMX-90031/200 mL);
(2) Continuous culture for 3 days, removing old solution with a pipette, and adding 2mL of lipid-forming induced differentiation medium B (OriCell, MUXMX-90031/200 mL);
(3) After culturing for 24 hours, removing the lipid-forming induced differentiation culture medium B solution, adding 2mL of the lipid-forming induced differentiation culture medium A solution again, and continuing culturing for 3 days;
(4) According to the time sequence, the lipid-forming induction differentiation culture medium A liquid and the lipid-forming induction differentiation culture medium B liquid are used for 3 to 5 times in turn, and then the lipid-forming induction differentiation culture medium B liquid is used for continuous culture for 4 to 7 days, and the liquid is changed every 2 to 3 days;
(5) After 3 weeks of induction culture, oil red O staining was performed until the lipid droplets became round and large enough (lipid droplet volume was greater than 40% of the cell volume).
1.2 Oil red O dyeing method
(1) Taking out the induced differentiated cells, and washing with PBS for 3 times for 5min each time;
(2) 200 mu L of paraformaldehyde solution with the mass fraction of 4% is added, and the mixture is fixed for 30min in a refrigerator at the temperature of 4 ℃;
(3) Discarding 4% paraformaldehyde solution, and washing with PBS for 3 times for 5min each time;
(4) Discarding PBS, adding 1mL of oil red O dye solution working solution (purchased from OriCell, OILR-10001) (storage solution according to volume ratio: distilled water=3:2, mixing well, filtering with neutral filter paper), and incubating at room temperature for 30min;
(5) Discarding the working solution of the oil red O dye liquor, and flushing with PBS for 3 times, each time for 5min;
(6) Rinsed once with distilled water, observed in an inverted phase contrast microscope and photographed.
2.1 Chondrogenic induced differentiation
(1) The OriCell mouse bone marrow mesenchymal stem cells are selected to be cartilage induced and differentiated kit (purchased from OriCell, MUXMX-90041/200 mL) and the kit is prepared2ML of mouse bone marrow mesenchymal stem cell chondrogenic differentiation additive I (hereinafter referred to as additive I) is added in totalA premix solution was prepared in 97mL of a cell basal medium (hereinafter referred to as basal medium);
(2) Taking 40 ten thousand third-generation cells, digesting and centrifuging, transferring the cells into a 15mL centrifuge tube, and centrifuging at 800rpm for 5min;
(3) Discarding the supernatant, adding 0.5mL of premix, re-suspending the precipitate obtained by the previous step of centrifugation, washing cells, and centrifuging at 560rpm for 5min at room temperature;
(4) Repeating the step (3), and cleaning the cells again;
(5) Adding a cartilage-forming differentiation complete medium of the mesenchymal stem cells of the mice (hereinafter referred to as an additive II) according to a proportion (10 mu L of the additive II is added into 1mL of premix), sucking the additive II with a dosage required by an experiment, adding the additive II into the premix with a corresponding volume, and preparing the complete medium of the cartilage-forming differentiation, and gently blowing and uniformly mixing;
(6) Re-suspending the precipitate obtained in the step (4) by using 0.5mL of cartilage-forming complete culture medium, and centrifuging at 560rpm for 5min at room temperature again;
(7) The centrifuge tube lid was unscrewed for gas exchange and placed in an incubator at 37 ℃ with 5% CO2 for incubation (centrifuge tube was not shaken for 24 h).
(8) Starting from inoculation, replacing cells with fresh chondrogenic complete medium every 2-3d, and taking about 0.5mL chondrogenic differentiation complete medium per tube, taking care not to suck out cartilage balls;
(9) After the cartilage induction complete culture medium is replaced, the bottom of the centrifugal tube is flicked to separate the cartilage balls from the bottom of the tube and suspend the cartilage balls in the liquid. Slightly unscrewing the cover of the centrifugal tube, and placing the tube into an incubator with the temperature of 37 ℃ and the concentration of 5% CO2 for continuous induction culture;
(10) After a typical duration of 21-28 days of induction, the cartilage spheres may be formalin-fixed and paraffin-embedded sectioned and finally stained with alisxin blue.
2.2 Allinnet blue staining experiments
2.2.1 Paraffin section was made
2.2.1.1 Fixing, namely cleaning the induced cartilage balls by PBS, soaking in 4% paraformaldehyde solution (purchased from Biyun Tian, P0099) and fixing for more than 30min;
2.2.1.2 dehydration, namely dehydration of the fixed cartilage ball by using gradient concentration alcohol in the following steps of 50% alcohol-70% alcohol-80% alcohol-95% alcohol-absolute alcohol, wherein each stage is 30min;
2.2.1.3, because alcohol and paraffin are not compatible, the dehydration needs to be transited by dimethylbenzene in the following way:
(1) Uniformly mixing dimethylbenzene and absolute alcohol according to a volume ratio of 1:1, and soaking cartilage balls in the mixture for 2 hours;
(2) Soaking cartilage balls in pure xylene for 1.5h;
(3) Changing new dimethylbenzene, and continuously soaking for 1h;
2.2.1.4 wax impregnation to remove the transparencies from the cartilage balls, wax impregnation treatment is required to allow paraffin to penetrate into the interior for embedding:
(1) Uniformly mixing dimethylbenzene and paraffin according to a volume ratio of 1:1, soaking cartilage balls in the mixture, and placing the mixture in a 40 ℃ oven for 40min;
(2) Soaking the cartilage balls treated in the step (2) in pure paraffin, and placing the pure paraffin in a 55 ℃ oven for 30min;
2.2.1.5 embedding, namely taking out the cartilage ball, placing the cartilage ball in a mould, pouring paraffin, standing and cooling, taking out the cartilage ball after the paraffin is fully cooled and formed, and trimming wax blocks.
2.2.1.6 Slicing, namely continuous slicing, wherein the thickness of each slice is 3 mu m;
2.2.1.7 sticking the cartilage ball slice to the glass slide by using an adhesive, and drying in a 35 ℃ oven;
2.2.1.8 dewaxing:
(1) Xylene soaked sections for 15min, and new xylene soaked sections for 10min;
(2) Mixing dimethylbenzene and absolute alcohol uniformly according to a volume ratio of 1:1, and soaking and slicing for 10min;
(3) Sequentially soaking the slices in 95%, 85%, 70% and 50% alcohol for 10min, and air drying.
2.2.2 Alinixin blue staining
(1) Dripping alixin blue staining solution on the paraffin section, completely covering the specimen, and staining for 1h in a 37 ℃ water bath kettle;
(2) Washing the glass slide with tap water for 5min;
(3) Dehydrating the slice with gradient ethanol (50% ethanol-70% ethanol-80% ethanol-95% ethanol-anhydrous ethanol) for 5min at each concentration for 1 time, and air drying in a fume hood while transparent with xylene;
(4) After the neutral resin is sealed, the neutral resin is observed and photographed under an inverted microscope.
3.1 Osteogenic induced differentiation
(1) Formulated as osteoinductive differentiation complete medium (available from OriCell, MUXMX-90021/200 mL) to be usedThe high-quality fetal bovine serum (20 mL) and the osteogenic differentiation additive (3 mL) in the osteogenic differentiation kit of the mesenchymal stem cells of the mice are all addedBasal medium (177 mL);
(2) Taking 40 ten thousand second generation GT-MSCs cells, inoculating the cells onto a six-hole plate according to a plating method, uniformly distributing the cells, discarding a common culture medium (a high-sugar DMEM culture medium without phenol red) when the fusion density reaches 80% -90% after the cells are subjected to wall-attached culture for 2 days, washing the cells 3 times by using PBS, adding 2mL of an osteogenic differentiation complete culture medium for induction, changing a liquid every three days (the osteogenic differentiation complete culture medium), inducing morphological change and growth condition of the cells after 4 weeks, and carrying out staining detection by alizarin red after calcium nodules appear. To prevent osteoblast shedding, it is suggested that after a large number of calcium nodules appear during the osteogenesis, the replacement form is changed to a half replacement every two days (osteogenesis induced differentiation complete medium).
3.2 Alizarin Red staining
(1) Taking out the cells after the osteogenesis differentiation, discarding the complete osteogenesis differentiation culture medium, and flushing for 3 times with PBS for 5min each time;
(2) 200 mu L of paraformaldehyde solution with the mass fraction of 4% is added, and the mixture is fixed for 30min in a refrigerator at the temperature of 4 ℃;
(3) Discarding 4% paraformaldehyde solution, and washing with PBS for 3 times for 5min each time;
(4) 1mL alizarin red dye solution (purchased from OriCell, ALIR-10001) is added into each hole, and the dyeing treatment is carried out for 3-5min;
(5) Discarding alizarin red dye liquor, and repeating the step (3);
(6) Osteoinductive differentiation staining results in the plates were observed under an inverted phase contrast microscope and recorded.
As can be seen from FIG. 6, a large number of lipid droplets were seen in the cytoplasm after 3 weeks of adipogenesis, about 85% of cells were positive (B in FIG. 6) after oil red O staining, alizarin red staining results showed that cells were able to exhibit a large amount of calcium salt deposition after 4 weeks of osteogenic differentiation, about 80% of cells were positive (A in FIG. 6), and in chondrogenic differentiation, a Li Xinlan primitive immunohistochemical staining showed that the induced group of aggregated chondrocytes (C in FIG. 6) after 4 weeks of induction, the above results showed that TG-MSCs had adipogenic, osteogenic, chondrogenic multipotential differentiation potential, and mesodermal differentiation direction, thereby demonstrating that TG-MSCs had the potential to induce differentiation into mesoderm.
Example 5
In this example, the hormone regulating function of the testicular interstitial cells was identified by qualitative analysis of the G protein-coupled receptor gene RXFP2 (receptor for the primary product INSL3 of testicular interstitial cells) by nucleic acid gel electrophoresis technique, and the specific procedures and results were as follows.
(1) Preparation of running buffer
The nucleic acid electrophoresis buffer was prepared as a TAE buffer, and the solution was diluted to 1 XTAE buffer. The 50×TAE buffer formulation is shown in Table 1.
TABLE 150 xTAE Buffer formulation (50 times dilution for use)
Reagent(s)Weighing valueMethod of
Tris (trometamol)242gPlacing the mixture in a 1L beaker, adding about 600mL of deionized water, and fully and uniformly stirring;
Na2EDTA·2H2O37.2g
CH3 COOH (glacial acetic acid)57.1mLAfter sufficient dissolution, the pH was adjusted to 8.3 with NaOH and deionized water was added to a volume of 1L.
(2) Preparation of agarose gel
Washing the gel-making mould and comb with distilled water, placing on a gel-making flat plate, closing the edge of the mould, setting up the comb, preparing 1% agarose gel (100 mL 1 xTAE buffer+1g agarose), heating to dissolve, adding 10 mu LYEAGREEN nucleic acid dye (10000 x, purchased from the following holothurian, 10204 ES), fully mixing, pouring into the mould, and waiting for cooling;
(3) After 30-45min at room temperature, the gel is completely coagulated, the comb is carefully pulled out, and the gel is placed in an electrophoresis tank;
(4) Pouring electrophoresis buffer solution into the electrophoresis tank, preferably 1mm beyond the gel surface, if bubbles exist in the sample hole, and removing;
(5) Adding 10 Xvolume of loading buffer (10213 ES from the living organism of the next year) into the DNA sample, mixing, and slowly adding the sample mixture into the immersed gel sample adding hole by using a gun;
(6) And (3) switching on a power supply, wherein red is a positive electrode, black is a negative electrode, and the DNA sample is cut and recorded to swim from the negative electrode to the positive electrode (one end close to the sample adding hole is negative). The voltage is generally 60-100V, and the electrophoresis is carried out for 20-40 min;
(7) Judging whether electrophoresis is stopped or not according to the electrophoresis position of the indicator;
(8) After electrophoresis, the power supply is turned off, the electrophoresis band and the position thereof are observed on a gel imager, and the size of the amplified product is compared with a standard Marker of nucleic acid molecular weight.
The results in FIG. 7 show that the normal control group, the solvent control group and the different administration experimental groups all express RXFP2 positive, and GT-MSCs have hormone regulating function.
Example 6
In this example, the hormone regulating function of the testicular mesenchymal cells was identified by qualitative analysis of the G protein-coupled receptor gene RXFP2 (receptor of the primary product INSL3 of the testicular mesenchymal cells) of GMSCs by Western blotting (Western Blot), and the specific procedures and results are as follows.
1. Cellular protein extraction and concentration determination
1.1 Total cellular protein extraction
(1) Spreading the cell plates into a 60mm culture dish, and extracting cell proteins after the cells are treated by the medicine;
(2) Preparing RIPA lysate (purchased from Panera, AAPR, 51-100) and PMSF (purchased from 100mM, purchased from Biotol, B14001) on ice for dissolving, placing PBS on a refrigerator for precooling at 4 ℃, preparing a 1.5mL EP tube on ice for use, cleaning a cell scraper, and drying in a drying box for later use;
(3) Preparing a cell lysate working solution according to the cell quantity and the cell volume (1 mL/1×107 cells), namely preparing the working solution by (calculated according to the volume ratio, RIPA lysate: PMSF=100:1), shaking and uniformly mixing, and then placing on ice for standby, and paying attention to the preparation for use at present;
(5) Taking out the cells, discarding the high-sugar DMEM culture medium without phenol red in the culture dish, and gently washing the culture medium with PBS for 3 times to wash off the fetal bovine serum in the culture medium, thereby avoiding influencing protease inhibitors;
(4) Adding a proper amount of lysate into each dish of cells (80 mu L of cell lysate is added into each dish with the diameter of 60 mm), rapidly scraping cells at the bottom of the dish by using a cell scraper, scraping the cells as completely as possible, scraping the cells sufficiently, transferring the lysate containing cell fragments into a 1.5mL EP tube, and performing lysis on ice for 30min sufficiently, wherein the cell scraper needs to be replaced between different cells, and the whole process is performed on ice to avoid protein degradation;
(5) Ultrasonically crushing each group of cell lysate for 4 times by using a homogenizing ultrasonic instrument, wherein each time is 5s, and the interval is 3 s;
(6) Pre-cooling the centrifuge to 4 ℃ in advance, placing 1.5mL of EP tube in the centrifuge and balancing, and centrifuging at 13500rpm for 20min at 4 ℃;
(7) Taking supernatant and total cell proteins after centrifugation, subpackaging into 1.5mL EP tubes, simultaneously subpackaging 6 mu L for measuring protein concentration, adding 5 Xloading buffer solution according to the ratio of 5 Xloading buffer solution to protein=1:4, heating the EP tubes on a 100 ℃ dry constant temperature heater for 10min after uniform mixing, placing the EP tubes on ice for cooling, identifying groups, and storing in a-20 ℃ refrigerator after the extraction date.
1.2 Protein concentration determination
(1) Preparation of 1.5mL EP tube, PBS, BSA standard protein (from BCA kit, purchased from Panera, AAPR 161-30);
(2) Preparing a BSA protein standard sample with the concentration of 0.5 mug/mL by using a protein standard substance preparation solution for preparing a standard curve;
(3) Preparing BCA working solution, namely preparing an appropriate amount of BCA working solution according to the ratio of reagent A to reagent B=50:1 according to the required amount of 200 mu L added to each hole, and fully and uniformly mixing;
(4) Adding standard substances into a 96-well plate according to the sequence shown in Table 2, taking an average value by dividing 3 complex wells, and setting a concentration gradient to prepare a protein standard curve;
TABLE 2 protein standard curve
Sequence number12345678
Standard substance concentration (μg/mL)00.0250.050.10.20.30.50.5
PBS(μL)2019181612840
Standard substance after dilution (MuL)01248121820
(5) Diluting a protein sample to be detected by using PBS 10 times, namely adding 18 mu L of PBS and 2 mu L of protein sample into each hole of a 96-well plate, and setting an average value of 3 multi-hole spheres for each sample to reduce errors;
(6) 200 mu L of BCA working solution is added into each hole, the holes are covered with a cover and then are placed in a constant-temperature oscillator with the temperature of 37 ℃ of an ELISA plate to shake for 30min, and the result is prevented from being influenced by bubbles in the sample loading process;
(7) Taking out the 96-well plate, cooling to room temperature, opening the plate cover, placing on an enzyme-labeled instrument, measuring the absorbance (OD) with the wavelength of 562nm, setting the standard protein concentration as the abscissa (mg/mL), drawing a standard protein curve (as shown in figure 9), displaying a unitary once equation corresponding to R2 and the straight line, if R2 is more than 0.995, proving that the model is reliable, substituting the measured absorbance of each sample into the equation to obtain the corresponding protein concentration, dividing the obtained protein concentration by the dilution factor, and obtaining the protein concentration of the sample.
Western Blot detection of target protein expression level
2.1 Preparation of Polyacrylamide gel (SDS-PAGE)
(1) Cleaning a BIO-RAD glass plate and a comb with distilled water in advance, placing the BIO-RAD glass plate and the comb in a drying box for drying, clamping the glass plate with a glue making clamp, aligning the bottom, clamping the glass plate on a glue making frame, detecting leakage with distilled water, and after no leakage is confirmed, using filter paper to distill water and suck the distilled water to dry, so that glue making can be performed;
(2) Preparing concentrated glue and separating glue, namely selecting separating glue and concentrated glue with proper concentrations according to requirements, preparing reagents according to the table 3, preparing the separating glue and the concentrated glue, preparing the separating glue firstly, and preparing the concentrated glue after the separating glue is solidified, wherein the solidification time of the separating glue and the separating glue is about 30 minutes.
TABLE 3 preparation of SDS-PAGE separating gel and concentrating gel
(3) After the preparation of the separating gel is completed, the separating gel solution is reversely and uniformly mixed up and down, the gap of the glass plate is firstly injected into the uniformly mixed separating gel solution, the height is about 3/5-4/5 of that of the glass plate, then 75% alcohol liquid is used for sealing, air is isolated to enable the separation to be quickly solidified, air bubbles are emptied at the same time, the boundary of the separating gel is kept horizontal, 75% alcohol is poured out after the separating gel is solidified, filter paper is used for sucking dry, the separating gel is not touched, then concentrated gel is injected until the glass plate is filled, then a comb is quickly and flatly inserted, air bubbles are avoided in the process, the action of inserting the comb is quick, and the concentrated gel is prevented from being solidified in advance;
(4) Concentrating the gel at room temperature for about 30min to solidify, placing the prepared gel plate in ddH2 O storage solution for moisturizing, and storing in a refrigerator at 4deg.C for use after 1 week.
3. Western immunoblotting (Western Blot)
(1) Taking out gel prepared in advance within 1 week from a refrigerator at the temperature of 4 ℃, correctly clamping a gel plate in a vertical electrophoresis tank, adding enough electrophoresis liquid into the tank to be flush with a glass plate, and slowly and vertically pulling out a comb, wherein the aim of avoiding damaging a sample loading hole is fulfilled;
(2) Loading, namely loading the protein liquid according to the same mass, wherein the loading amount of each sample is 20 mug, converting the loading volume according to the protein concentration measured by a BCA detection method, and sequentially adding the corresponding protein sample and 5 mug of pre-dyed protein Marker (purchased from Thermo Siamer);
(3) Electrophoresis, namely placing the inner tank into the outer tank, adding a proper amount of electrophoresis liquid into the outer tank to enable the electrophoresis liquid to permeate through the metal wires at the bottom of the inner tank, and covering the tank cover of the electrophoresis tank. The positive electrode and the negative electrode of the power supply are correctly connected, the power supply is turned on, the parameters are set to be 60V constant pressure running concentrated glue, after the Marker strips of the pre-dyed protein are obviously separated, the pressure can be increased to 120V constant pressure running separation glue until the Marker strips corresponding to the molecular weight of the target protein are sufficiently clear and separated, namely, the tube wall power supply is realized, and the electrophoresis is finished;
(4) Electric conversion:
a. cutting a proper PVDF film according to the size of the gel, marking the left and right sides and the front and back sides, soaking the PVDF film in methanol solution for 5min, and activating the PVDF film;
b. and (3) cutting gel, namely taking out a glass plate, tilting the glass plate by using a warping plate, cutting a required gel strip at a relative molecular weight position of gel by referring to the Marker strip position, and measuring the molecular weight of protein in the experiment as shown in Table 4.
TABLE 4 relative molecular weights for the desired proteins of interest
Protein to be detectedMolecular weight (kDa)
Anti-LC3 Rabbit mAb14-16
Anti-P62Rabbit mAb60
Anti-Nanog Rabbit mAb29-42
Anti-Oct4 Rabbit mAb45
Anti-GAPDH Rabbit mAb36
Anti-β-actin Rabbit mAb42
Anti-RXFP2 Rabbit mAb86
C. Preparing a tray for transferring films, filling enough electro-transfer buffer solution prepared in advance, putting the film transfer clips, a foam-rubber cushion and filter paper into the tray for pre-wetting, enabling the electro-transfer buffer solution to pass through the devices, placing the foam-rubber cushion and 3 layers of cut filter paper on a negative plate of the film transfer clips according to the order, carefully transferring the cut rubber to the filter paper, then reversely buckling a PVDF film on the gel, paying attention to the left-right order, lightly evacuating bubbles, avoiding touching a protein surface of the PVDF film by hands, pasting another layer of foam-rubber cushion and the filter paper on a positive plate, and tightly closing the film transfer clips after only pressing the positive plate;
d. The method comprises the steps of electrotransfer, namely placing a transfer film clamp into a transfer film groove, adding enough electrotransfer buffer solution and an ice plate, covering an electrotransfer groove cover, transferring the transfer film groove into an ice box, filling ice blocks with ice, connecting a power supply, adjusting parameters, starting transfer film, wherein the transfer film parameters of the experiment are constant current of 200mA, and the electrotransfer time is about the molecular weight plus 30min;
e. Sealing, namely, sealing liquid (5% skimmed milk) can be prepared in advance at the beginning of film transfer, and the sealing liquid is placed on a shaking table for uniform mixing so as to prevent the follow-up luminous background from being affected incompletely by the dissolution of the skimmed milk powder, and after the electric transfer is finished, placing the PVDF film into the sealing liquid, and slowly sealing the shaking table for 1h at normal temperature;
f. Transferring the corresponding PVDF membrane into the corresponding primary anti-dilution liquid according to the Marker strip position phase, and slowly shaking overnight on a shaking table at 4 ℃ for more than 8 hours;
g. washing PVDF membrane with TBST the next day, placing it on a room temperature shaking table for rapid washing for 10min, repeating for 3 times;
h. Transferring the PVDF membrane into secondary antibody diluent prepared in advance, and slowly incubating on a room-temperature shaking table for 1h;
i. Washing PVDF film with TBST, placing it on a room temperature shaking table, rapidly washing for 10min, repeating for 3 times, and washing off secondary antibody diluent;
j. Preparing chemiluminescent liquid according to the proportion of the luminescent liquid A to B=1:1, fully and uniformly mixing, and performing light-shielding operation in the operation process, placing PVDF film protein surface upwards in a chemiluminescent instrument after uniformly attaching the luminescent liquid to the strip, opening Image Lab 3.0.1 software, and performing light emission after setting parameters and exposure time;
k. The method comprises the steps of strip analysis, namely, storing and deriving images, comparing gray values of proteins to be detected among different groups by using Image Lab 3.0.1 software, aligning the internal references of each group to obtain a ratio by taking the gray value of the internal reference of the control group as a reference, comparing the gray value of the target protein value of each sample with the ratio of the internal reference to obtain the relative gray value of each experimental group, and obtaining the relative multiples of the target protein expression of the other treatment groups by taking the target proteins of the control group as a reference. Each protein of interest was repeatedly tested 3 times and statistically analyzed using SPASS software.
In this example, living mice were subcutaneously injected with DES at different concentrations (DES concentrations of 0.1. Mu.g/kg.d, 1. Mu.g/kg.d, 10. Mu.g/kg.d, 100. Mu.g/kg.d), treated with no treatment (NC) and solvent (DM), and after the mice were bred, the testis tape of the mice was extracted, and GT-MSCs were cultured.
As shown in fig. 10, RXFP2 protein levels were down-regulated with increasing DES concentration, dose-dependent, and differences were statistically significant compared to the no-treatment control group (NC), indicating that hormonal regulation of DES-induced pediatric cryptorchism was affected.
Example 7
In this example, the effect of Western Blot (Western Blot) on the pluripotency of GT-MSCs by Nanog and Oct4 (Nanog and Oct4 are regulatory factors necessary for mesenchymal stem cells to maintain stem cells self-renewal and pluripotency) in subcultured 2 nd generation GT-MSCs was quantitatively analyzed by Western Blot to identify the pluripotency of testicular mesenchymal cells and the effect of DES on GT-MSCs pluripotency, and the method was carried out in the same manner as in example 6.
In this example, GT-MSCs were subcultured cells of passage 2, the group without any treatment was set as no-treatment control group (NC), the group treated with solvent was set as solvent control group (DM), chloroquine drug treatment 4H was set as CQ group (CQ), diethylstilbestrol drug treatment 24H was set as DES24H, DES treatment 24H and chloroquine treatment 1H was set as D+C24H.
As shown in FIG. 8, the experimental results demonstrate that the mechanism of DES-induced pediatric cryptorchidism is to inhibit Nanog and Oct4 protein expression by blocking autophagic flow, thereby affecting the pluripotency of GT-MSCs cells.
Example 8
In this example, LC3 (LC 3 is an autophagy-based marker) and P62 (autophagy degradation substrate marker) protein levels in subcultured generation 2 GT-MSCs were analyzed by Western blotting (Western Blot), and studies on the disease mechanism of DES-induced pediatric cryptorchism were explored, and the specific implementation method was the same as in example 6. The increase in the relative expression level of LC3-II/LC3-I reflects autophagosome formation, and promotes autophagy flow. The treatment groups DES treatment 12H (DES 12H), 24H (DES 24H), 48H (DES 48H) and des+cq combined treatment 12H (d+c12h), 24H (d+c24h), 48H (d+c48h) were set with the group without any treatment as the no-treatment control group (NC) and the group with solvent treatment as the solvent control group (DM).
As shown in FIG. 11, the experimental results indicate that DES inhibits autophagy of GT-MSCs, while chloroquine blocks autophagy flow (i.e., blocks degradation of LC 3), causing accumulation of LC3, and thus CQ and DES act synergistically to inhibit autophagy. Further demonstrated that DES induced autophagy of GT-MSCs was involved in mouse cryptorches and inhibited autophagy.

Claims (10)

Translated fromChinese
1.一种从小鼠睾丸引带组织培养获得睾丸引带间充质干细胞的方法,其特征在于,包括如下步骤:1. A method for obtaining gubernaculum testis mesenchymal stem cells from mouse gubernaculum testis tissue culture, characterized in that it comprises the following steps:S1.从新生0-3天的雄性小鼠中分离出引带组织,并清洗干净引带组织;S1. Isolate the gubernaculum tissue from newborn male mice aged 0-3 days and clean the gubernaculum tissue;S2.往引带组织中添加浓度为1mg/mL的Ⅰ型胶原酶进行消化分散后,转移至培养瓶,添加培养基进行静置原代培养,待原代培养至细胞贴壁,更换培养基;S2. Add 1 mg/mL type I collagenase to the girdle tissue for digestion and dispersion, transfer to a culture bottle, add culture medium for static primary culture, and replace the culture medium when the primary culture reaches cell attachment;S3.当培养至贴壁细胞融合率达到80%时,用胰蛋白酶点状消化细胞集落后,进行传代培养,传代培养至第3代建立细胞库,获得睾丸引带间充质干细胞。S3. When the fusion rate of adherent cells reaches 80%, the cell colonies are digested with trypsin in a dot-like manner and then subcultured. After subculture to the third generation, a cell bank is established to obtain gubernaculum testis mesenchymal stem cells.2.根据权利要求1所述的方法,其特征在于,所述的步骤S1中的清洗干净引带组织为用无菌的质量分数15%的PBS清洗引带组织3次,然后用青霉素/链霉素混合溶液浸泡3min,再用无菌的质量分数15%的PBS洗3次。2. The method according to claim 1 is characterized in that the cleaning of the leader tissue in step S1 is to clean the leader tissue with sterile 15% PBS for 3 times, then soak it in a penicillin/streptomycin mixed solution for 3 minutes, and then wash it with sterile 15% PBS for 3 times.3.根据权利要求1所述的方法,其特征在于,所述的步骤S2中的往引带组织中添加浓度为1mg/mL的I型胶原酶进行消化分散为每10条引带组织加入3mL 1mg/mLⅠ型胶原酶进行消化分散。3. The method according to claim 1 is characterized in that, in the step S2, adding 1 mg/mL type I collagenase to the girdle tissue for digestion and dispersion is performed by adding 3 mL of 1 mg/mL type I collagenase for digestion and dispersion for every 10 girdle tissues.4.根据权利要求1所述的方法,其特征在于,所述的步骤S2中的消化分散为37℃、250r/min消化2h。4. The method according to claim 1 is characterized in that the digestion dispersion in step S2 is performed at 37°C and 250 r/min for 2 hours.5.根据权利要求1所述的方法,其特征在于,所述的步骤S2中的培养基,按体积分数计算,组成为15%胎牛血清、1%青霉素/链霉素混合液、余量为不含酚红的高糖DMEM培养基。5. The method according to claim 1, characterized in that the culture medium in step S2 is composed of 15% fetal bovine serum, 1% penicillin/streptomycin mixture, and the balance is high-glucose DMEM culture medium without phenol red, calculated by volume fraction.6.根据权利要求1所述的方法,其特征在于,所述的步骤S2中静置原代培养的条件为5%CO2、37℃、湿度饱和。6 . The method according to claim 1 , wherein the conditions for static primary culture in step S2 are 5% CO2 , 37° C., and saturated humidity.7.根据权利要求1所述的方法,其特征在于,所述的步骤S3中所述的点状消化为先滴加1滴胰蛋白酶进行消化3min,再加入1mL胰蛋白酶酶进行完全分散消化3min。7. The method according to claim 1 is characterized in that the point digestion in step S3 is to first add 1 drop of trypsin for digestion for 3 minutes, and then add 1 mL of trypsin enzyme for complete dispersed digestion for 3 minutes.8.权利要求1-7任一项所述的方法制备得到的睾丸引带间充质干细胞。8. The gubernaculum testis mesenchymal stem cells prepared by the method according to any one of claims 1 to 7.9.权利要求8所述的睾丸引带间充质干细胞在诱导分化脂肪细胞、骨细胞和软骨细胞中的应用。9. Use of the gubernaculum testis mesenchymal stem cells according to claim 8 in inducing differentiation into adipocytes, osteocytes and chondrocytes.10.权利要求8所述的睾丸引带间充质干细胞在制备用于治疗隐睾症或激素调节产品中的用途。10. Use of the gubernaculum testis mesenchymal stem cells according to claim 8 in the preparation of products for treating cryptorchidism or hormone regulation.
CN202411273988.9A2024-09-122024-09-12 A method for obtaining gubernaculum testis mesenchymal stem cells from mouse gubernaculum testisPendingCN119082008A (en)

Priority Applications (1)

Application NumberPriority DateFiling DateTitle
CN202411273988.9ACN119082008A (en)2024-09-122024-09-12 A method for obtaining gubernaculum testis mesenchymal stem cells from mouse gubernaculum testis

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
CN202411273988.9ACN119082008A (en)2024-09-122024-09-12 A method for obtaining gubernaculum testis mesenchymal stem cells from mouse gubernaculum testis

Publications (1)

Publication NumberPublication Date
CN119082008Atrue CN119082008A (en)2024-12-06

Family

ID=93660069

Family Applications (1)

Application NumberTitlePriority DateFiling Date
CN202411273988.9APendingCN119082008A (en)2024-09-122024-09-12 A method for obtaining gubernaculum testis mesenchymal stem cells from mouse gubernaculum testis

Country Status (1)

CountryLink
CN (1)CN119082008A (en)

Similar Documents

PublicationPublication DateTitle
CN109136174B (en)Stem cell-derived exosome preparation for delaying senescence
CN107881197A (en)One kind immortalizes cow rumen epithelial cell line and its construction method
CN101955907A (en)Pig small intestine epithelial cell line and construction method thereof
CN104480062A (en)Separation and culture method for different cellular components of human mammary tissue
JP5388297B2 (en) Adipo cluster
CN106047819A (en)Immortalized goat small intestine epithelial cell line and establishment method thereof
CN110423720A (en)A kind of amnioic epithelium stem cell is induced to differentiate into the method and its application of functional islets β cell
CN105062970B (en)A kind of derivant and induction differentiation complete medium that mescenchymal stem cell is induced to neuroblast
CN110684737B (en)Induced pluripotent stem cell of RPE65 gene mutation patient
CN119799626A (en) Mesenchymal stem cells for resisting ovarian granulosa cell aging and preparation method thereof
CN108486039B (en) A method for inducing the differentiation of human adipose stem cells into Leydig cells by small molecules
CN105112359A (en)Separating and cultivating method of mouse umbilical cord mesenchymal stem cells
CN119082008A (en) A method for obtaining gubernaculum testis mesenchymal stem cells from mouse gubernaculum testis
CN113444681B (en) A kind of isolation and primary culture method of chicken pineal cells
CN113577109B (en)Anti-aging strategy based on embryonic stem cells
CN110951672B (en) A mouse endometrial epithelial cell and its 3D differentiation culture model construction method
CN111269940A (en) A method for direct transdifferentiation of mesenchymal stem cells into sperm using the transcription factor FOXO1
CN110205283B (en) A method for inducing human amniotic epithelial cells to differentiate into retinal pigment epithelial cells and its application
CN115029305A (en)Separation and identification method for pig FAPs (FAPs) cells and application of FAPs cells
CN109666627B (en) Method for inducing umbilical cord mesenchymal stem cells to differentiate into Leydig cells with small molecules
CN115322959B (en)16P11.2 microdeletion syndrome related autism induced pluripotent stem cell, preparation method and application
CN110592008A (en) Culture method of canine bone marrow mesenchymal stem cells
CN113774015B (en)Method for in vitro induction of oogenic cell differentiation into oocyte
CN114736847B (en)Method for rapidly obtaining primary gonad cells of giant salamander
Viveiros et al.Comparison of techniques for corneal epithelium cell culture for the collection of conditioned medium

Legal Events

DateCodeTitleDescription
PB01Publication
PB01Publication
SE01Entry into force of request for substantive examination
SE01Entry into force of request for substantive examination

[8]ページ先頭

©2009-2025 Movatter.jp